piperocaine monohydrochloride Report issue

Small molecule Experimental
MeSH PubChem

Active Ingredient History

Piperocaine (Metycaine) is a local anesthetic drug. It is an ester and primarily is a sodium channel blocker. Piperocaine can partially inhibit dopamine. It is known as a alpha-1-proteinase inhibitor. Used in the form of its hydrochloride as a local or spinal anesthetic and in dental anesthesia. Can cause toxic reactions. Piperocaine Hydrochloride is in the list of Bulk Drug Substances Nominated for Use in Compounding Under Section 503A, FDA Act. Piperocaine hydrochloride is a small, white odorless crystals or a white crystalline powder, stable in air, freely soluble in water, alcohol and chloroform.   NCATS

Chemistry

  • SMILES: CC1CCCCN1CCCOC(=O)C2=CC=CC=C2
  • InChIKey: YQKAVWCGQQXBGW-UHFFFAOYSA-N
  • Mol. Mass: 261.3593
  • ALogP: Missing data
  • ChEMBL Molecules: Missing data
More Chemistry

Pharmacology

Alternative names

(+/-)-2-methyl-1-piperidinepropanol benzoate (ester) | 2-methylpiperidinepropanol benzoate | neothesin | piperocaine | piperocaine hydrochloride | piperocaine, (+-)-isomer | piperocaine monohydrochloride | piperocaine monohydrochloride, (+-)-isomer

Indications (1)

Approved Indications (1)


 

Anesthetics, Local

Experimental Indications - Clinical Trial Phases 1-4 (0)

Feedback

Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

Report issue